|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5870 EUR | +14.87% |
|
+4.08% | -61.78% |
| 13/07 | AB Science to Discontinue Three Masitinib-related Clinical Studies | MT |
| 11/07 | AB Science streamlines its portfolio and refocuses on two molecules |  |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +14.87% | +4.08% | -34.63% | -49.22% | -61.78% | -63.54% | -85.23% | -95.98% | -95.76% | 46.55M | |
| +0.96% | +6.19% | +2.10% | +19.84% | +25.49% | +57.14% | +25.48% | +69.68% | +125.42% | 324B | |
| +1.80% | +5.04% | -3.18% | +29.87% | +15.62% | +25.39% | -11.68% | -17.68% | +44.38% | 68.88B | |
| +1.16% | +8.12% | +7.99% | +29.24% | +23.85% | +44.38% | +91.57% | +102.60% | +739.38% | 9.72B | |
| +1.64% | +0.15% | +3.24% | +14.77% | +5.30% | +3.40% | -2.15% | -27.79% | +40.94% | 8.37B | |
| +1.13% | +1.51% | -2.77% | -21.21% | -35.31% | -21.44% | -4.05% | -33.11% | - | 4.32B | |
| +4.90% | +5.79% | +12.80% | -20.99% | -33.36% | -38.81% | +21.37% | +40.53% | +84.13% | 3.83B | |
| -4.00% | +0.71% | +0.76% | +18.03% | +24.91% | -5.66% | +12.85% | -35.82% | - | 3.62B | |
| +3.20% | +0.70% | +2.03% | -3.46% | -3.92% | +42.92% | +58.48% | +75.36% | +116.36% | 2.68B | |
| -4.07% | -2.45% | +0.10% | -20.88% | -20.25% | -8.03% | -10.93% | +46.54% | - | 2.04B | |
| -5.78% | +0.89% | +17.75% | -5.40% | -3.49% | -16.30% | +24.72% | -28.32% | - | 1.84B | |
| -2.53% | -4.40% | +8.87% | -12.77% | -16.14% | -24.10% | -22.58% | -10.28% | -45.18% | 1.68B | |
| -.--% | -.--% | - | - | - | - | - | - | - | 1.64B | |
| +0.70% | +5.92% | +18.43% | +85.50% | +157.24% | +189.42% | +1,499.26% | +707.05% | - | 1.17B | |
| +2.08% | +1.89% | -3.06% | -40.83% | -40.18% | +36.28% | +42.78% | +19.25% | +448.14% | 1.13B | |
| -5.95% | -6.07% | -4.43% | -30.50% | -20.96% | -37.80% | -34.13% | - | - | 1.12B | |
| -6.45% | -5.20% | +1.22% | +4.80% | +10.03% | +1.69% | +80.87% | +5.92% | - | 1.1B | |
| +1.65% | +2.50% | +4.24% | -5.60% | -7.53% | +0.58% | +44.34% | +87.53% | +82.75% | 1.07B | |
| -3.06% | -5.56% | +2.50% | -22.10% | -26.19% | -42.19% | -77.97% | -83.81% | - | 850M | |
| +3.40% | +1.25% | +2.10% | -12.90% | -12.59% | -42.42% | -10.99% | -42.96% | -65.77% | 840M | |
| Average | +0.30% | -1.13% | +1.90% | -2.31% | -1.01% | +5.31% | +86.42% | +43.26% | +134.07% | 21.98B | |
| Weighted average by Cap. | +0.92% | +2.50% | +1.55% | +19.82% | +21.49% | +47.08% | +23.71% | +52.75% | +123.89% |
- Stock Market
- Stocks
- AB Stock
- Sector AB Science
Select your edition
All financial news and data tailored to specific country editions
